Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.03
HCA's Cash to Debt is ranked lower than
91% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 0.36 vs. HCA: 0.03 )
Ranked among companies with meaningful Cash to Debt only.
HCA' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: N/A
Current: 0.03
Equity to Asset -0.23
HCA's Equity to Asset is ranked lower than
97% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. HCA: -0.23 )
Ranked among companies with meaningful Equity to Asset only.
HCA' s Equity to Asset Range Over the Past 10 Years
Min: -0.5  Med: 0.21 Max: 0.42
Current: -0.23
-0.5
0.42
Interest Coverage 3.60
HCA's Interest Coverage is ranked lower than
71% of the 191 Companies
in the Global Medical Care industry.

( Industry Median: 6.55 vs. HCA: 3.60 )
Ranked among companies with meaningful Interest Coverage only.
HCA' s Interest Coverage Range Over the Past 10 Years
Min: 1.42  Med: 2.06 Max: 3.55
Current: 3.6
1.42
3.55
F-Score: 8
Z-Score: 2.07
M-Score: -2.83
WACC vs ROIC
3.94%
19.18%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 14.84
HCA's Operating margin (%) is ranked higher than
75% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 7.16 vs. HCA: 14.84 )
Ranked among companies with meaningful Operating margin (%) only.
HCA' s Operating margin (%) Range Over the Past 10 Years
Min: 8.62  Med: 13.00 Max: 15.07
Current: 14.84
8.62
15.07
Net-margin (%) 5.54
HCA's Net-margin (%) is ranked higher than
54% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 4.82 vs. HCA: 5.54 )
Ranked among companies with meaningful Net-margin (%) only.
HCA' s Net-margin (%) Range Over the Past 10 Years
Min: 2.37  Med: 4.31 Max: 7.58
Current: 5.54
2.37
7.58
ROA (%) 6.96
HCA's ROA (%) is ranked higher than
66% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 3.77 vs. HCA: 6.96 )
Ranked among companies with meaningful ROA (%) only.
HCA' s ROA (%) Range Over the Past 10 Years
Min: 2.79  Med: 5.25 Max: 9.71
Current: 6.96
2.79
9.71
ROC (Joel Greenblatt) (%) 31.00
HCA's ROC (Joel Greenblatt) (%) is ranked higher than
65% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 18.36 vs. HCA: 31.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HCA' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 19.54  Med: 30.17 Max: 37.66
Current: 31
19.54
37.66
Revenue Growth (3Y)(%) 9.00
HCA's Revenue Growth (3Y)(%) is ranked higher than
60% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 6.60 vs. HCA: 9.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HCA' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -1.8  Med: 7.70 Max: 13.4
Current: 9
-1.8
13.4
EBITDA Growth (3Y)(%) 8.30
HCA's EBITDA Growth (3Y)(%) is ranked higher than
57% of the 148 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. HCA: 8.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HCA' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -6.1  Med: 4.40 Max: 24.4
Current: 8.3
-6.1
24.4
EPS Growth (3Y)(%) 12.70
HCA's EPS Growth (3Y)(%) is ranked higher than
65% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: 6.60 vs. HCA: 12.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HCA' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 6.90 Max: 88.4
Current: 12.7
0
88.4
» HCA's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-05)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

HCA Guru Trades in Q2 2015

Steven Cohen 7,100 sh (New)
Jim Simons 64,100 sh (New)
John Burbank 61,554 sh (New)
Joel Greenblatt 25,396 sh (New)
Louis Moore Bacon 123,119 sh (+1997.43%)
Paul Tudor Jones 34,599 sh (+228.51%)
Vanguard Health Care Fund 7,647,300 sh (+8.08%)
Mario Gabelli 27,000 sh (+8.00%)
Larry Robbins 5,178,578 sh (unchged)
John Paulson 4,711,900 sh (unchged)
Andreas Halvorsen Sold Out
Caxton Associates Sold Out
Lee Ainslie Sold Out
David Dreman 28,337 sh (-2.16%)
Steve Mandel 5,007,242 sh (-14.21%)
David Tepper 4,184,525 sh (-14.72%)
Robert Olstein 49,000 sh (-20.97%)
Pioneer Investments 165,368 sh (-73.29%)
» More
Q3 2015

HCA Guru Trades in Q3 2015

John Hussman 75,000 sh (New)
Jim Simons 516,400 sh (+705.62%)
Vanguard Health Care Fund 10,184,243 sh (+33.17%)
Larry Robbins 5,513,278 sh (+6.46%)
Mario Gabelli 27,225 sh (+0.83%)
John Paulson 4,711,900 sh (unchged)
John Burbank Sold Out
Louis Moore Bacon Sold Out
Robert Olstein Sold Out
Steve Mandel Sold Out
Joel Greenblatt Sold Out
Steven Cohen Sold Out
David Dreman 25,802 sh (-8.95%)
David Tepper 3,553,537 sh (-15.08%)
Pioneer Investments 56,819 sh (-65.64%)
Paul Tudor Jones 7,800 sh (-77.46%)
» More
Q4 2015

HCA Guru Trades in Q4 2015

Richard Perry 3,063,000 sh (New)
First Pacific Advisors 49,770 sh (New)
Steven Cohen 109,300 sh (New)
Louis Moore Bacon 130,000 sh (New)
Joel Greenblatt 247,339 sh (New)
George Soros 79,247 sh (New)
Larry Robbins 14,300,549 sh (+159.38%)
David Tepper 4,537,063 sh (+27.68%)
Paul Tudor Jones 9,619 sh (+23.32%)
Vanguard Health Care Fund 11,911,153 sh (+16.96%)
Mario Gabelli 27,800 sh (+2.11%)
Samuel Isaly 1,220,500 sh (unchged)
Pioneer Investments Sold Out
John Hussman Sold Out
John Paulson Sold Out
David Dreman 22,684 sh (-12.08%)
Jim Simons 262,500 sh (-49.17%)
» More
Q1 2016

HCA Guru Trades in Q1 2016

Pioneer Investments 90,037 sh (New)
Jeremy Grantham 5,500 sh (New)
Lee Ainslie 369,220 sh (New)
Joel Greenblatt 622,232 sh (+151.57%)
Steven Cohen 247,800 sh (+126.72%)
Mario Gabelli 50,400 sh (+81.29%)
David Dreman 25,171 sh (+10.96%)
Larry Robbins 14,675,592 sh (+2.62%)
First Pacific Advisors Sold Out
Jim Simons Sold Out
Louis Moore Bacon Sold Out
Paul Tudor Jones Sold Out
George Soros Sold Out
Vanguard Health Care Fund 11,682,053 sh (-1.92%)
Richard Perry 2,768,000 sh (-9.63%)
David Tepper 3,173,423 sh (-30.06%)
Samuel Isaly 1,107,100 sh (-9.29%)
» More
» Details

Insider Trades

Latest Guru Trades with HCA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:NYSE:FMS, OTCPK:FSNUY, NYSE:DVA, NYSE:UHS, OTCPK:IHHHF, OTCPK:RMSYF, OTCPK:BDULF, OTCPK:MCFFY, NYSE:MD, OTCPK:SKHCY, OTCPK:CAKFY, NAS:WOOF, NAS:ACHC, NAS:AMSG, OTCPK:BUHPF, NYSE:HLS, NAS:LPNT, NYSE:THC, OTCPK:LTGHY, NYSE:CHE » details
Traded in other countries:2BH.Germany,
HCA Holdings Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals; and rehabilitation hospitals. It also operates freestanding surgery centers.

HCA Holdings Inc was incorporated in Nevada in January 1990 and reincorporated in Delaware in September 1993. It is a health care services company in the United States. It operates 168 hospitals, comprised of 164 general, acute care hospitals; three psychiatric hospitals; and one rehabilitation hospital. In addition, it operates 116 freestanding surgery centers. Its facilities are located in 20 states and England. Its general, acute care hospitals typically provide services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by its general, acute care hospitals, freestanding surgery centers, diagnostic centers and rehabilitation facilities. Its psychiatric hospitals provide mental health care services through inpatient, partial hospitalization and outpatient settings. The Company is subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment. Some competing facilities are physician-owned or are owned by tax-supported government agencies and many others are owned by not-for-profit entities that may be supported by endowments, charitable contributions and/or tax revenues and are exempt from sales, property and income taxes. It also faces competition from specialty hospitals and from both its own and unaffiliated freestanding ASCs for market share in certain high margin services.

Top Ranked Articles about HCA Holdings Inc

Richard Perry Trims Time Warner, AIG The guru's largest 1st-quarter transactions
Richard Perry (Trades, Portfolio) co-founded private investment management firm Perry Capital LLC in 1988, which manages about $14 billion as of August 2008. The following are his largest deals during the first quarter: Read more...
All-In-One Screener Finds Week's Largest Insider Trades A recap of the most important transactions
The All-in-One Screener can be used to find insider buys and sells over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying to “$1,000,000+” and duration to "May 2016.” Read more...
John Paulson Trims Stake in Allergan, Time Warner Cable Event-driven investor's top 4th quarter trades
John Paulson (Trades, Portfolio) established Paulson & Co. Inc. as a merger arbitrage hedge fund manager, seeking to make money from situations when one public company announces plans to take over another. During the fourth quarter, he sold many stocks including the following. Read more...
John Paulson Sells Allergan, Precision Castparts, AIG Top sales by the investor during the 4th quarter
John Paulson (Trades, Portfolio) is the president and portfolio manager of Paulson & Co. Inc. Paulson was ranked by Absolute Return Magazine as the third-largest hedge fund in the world managing approximately $29 billion in merger, event and distressed strategies. The following are the guru's largest sales during the fourth quarter of 2015. Read more...
Richard Perry Invests in 3 Energy Stocks in 4th Quarter Investment in health care company was guru's largest transaction
Richard Perry (Trades, Portfolio), co-founder of Perry Capital LLC, purchased four new stakes in the fourth quarter, three of which are in energy-related companies. Read more...
An Overview of Appaloosa Management's Top 3 Holdings Analysis of David Tepper's top stocks and a general overview of growth rates and performance metrics on each
David Tepper (Trades, Portfolio) runs Appaloosa Management LP, a $2.9 billion hedge fund. It's important to analyze key holdings from prominent hedge funds because they have more analytical resources to analyze stocks than the majority of individual investors. Here is a look at Appaloosa's most interesting stock selections: Read more...
Steve Mandel Closes Position in Lowe's Lone Pine Capital founder's largest sales in the 3rd quarter
Steve Mandel (Trades, Portfolio) is the founder of Lone Pine Capital, a long/short equity money manager that he started in 1997. The firm uses fundamental analysis and bottom up stock picking to build the portfolio. Mandel uses both value and growth methodologies, and does not hold many stocks for very long. Read more...
Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer Its largest trades include Merck, HCA, Baxter
Edward Owens has worked in investment management for more than 30 years. He has managed the Vanguard Health Care Fund (Trades, Portfolio) since its inception in May 1984. The hedge fund has a portfolio composed of 82 stocks with a total value of $46,362 million and the following are the most weighted trades based on the impact on the portfolio during the third quarter. Read more...
David Tepper's Five Most Heavily Weighted Holdings General Motors, Apple are at the top of the list
If David Tepper (Trades, Portfolio) slips under some financial observers’ radars, he shouldn’t. At the end of the second quarter, Tepper, the founder of Appaloosa Management LP, was worth $10.7 billion and owned shares in 35 companies with a value of more than $4 billion. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 14.47
HCA's P/E(ttm) is ranked higher than
81% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 24.96 vs. HCA: 14.47 )
Ranked among companies with meaningful P/E(ttm) only.
HCA' s P/E(ttm) Range Over the Past 10 Years
Min: 4.08  Med: 14.12 Max: 19.67
Current: 14.47
4.08
19.67
Forward P/E 12.02
HCA's Forward P/E is ranked higher than
85% of the 72 Companies
in the Global Medical Care industry.

( Industry Median: 19.01 vs. HCA: 12.02 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 14.47
HCA's PE(NRI) is ranked higher than
83% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 24.96 vs. HCA: 14.47 )
Ranked among companies with meaningful PE(NRI) only.
HCA' s PE(NRI) Range Over the Past 10 Years
Min: 4.08  Med: 14.12 Max: 19.67
Current: 14.47
4.08
19.67
Price/Owner Earnings (ttm) 11.59
HCA's Price/Owner Earnings (ttm) is ranked higher than
78% of the 88 Companies
in the Global Medical Care industry.

( Industry Median: 27.45 vs. HCA: 11.59 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
HCA' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6.27  Med: 12.48 Max: 58.95
Current: 11.59
6.27
58.95
P/S 0.79
HCA's P/S is ranked higher than
68% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. HCA: 0.79 )
Ranked among companies with meaningful P/S only.
HCA' s P/S Range Over the Past 10 Years
Min: 0.32  Med: 0.63 Max: 1.07
Current: 0.79
0.32
1.07
PFCF 12.07
HCA's PFCF is ranked higher than
77% of the 112 Companies
in the Global Medical Care industry.

( Industry Median: 19.55 vs. HCA: 12.07 )
Ranked among companies with meaningful PFCF only.
HCA' s PFCF Range Over the Past 10 Years
Min: 4.19  Med: 11.79 Max: 17.22
Current: 12.07
4.19
17.22
POCF 6.37
HCA's POCF is ranked higher than
83% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 13.56 vs. HCA: 6.37 )
Ranked among companies with meaningful POCF only.
HCA' s POCF Range Over the Past 10 Years
Min: 2.58  Med: 5.78 Max: 8.53
Current: 6.37
2.58
8.53
EV-to-EBIT 10.88
HCA's EV-to-EBIT is ranked higher than
84% of the 177 Companies
in the Global Medical Care industry.

( Industry Median: 18.49 vs. HCA: 10.88 )
Ranked among companies with meaningful EV-to-EBIT only.
HCA' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.3  Med: 10.70 Max: 12.6
Current: 10.88
6.3
12.6
EV-to-EBITDA 8.11
HCA's EV-to-EBITDA is ranked higher than
81% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 12.81 vs. HCA: 8.11 )
Ranked among companies with meaningful EV-to-EBITDA only.
HCA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 7.90 Max: 9.4
Current: 8.11
5
9.4
PEG 2.79
HCA's PEG is ranked higher than
51% of the 79 Companies
in the Global Medical Care industry.

( Industry Median: 2.77 vs. HCA: 2.79 )
Ranked among companies with meaningful PEG only.
HCA' s PEG Range Over the Past 10 Years
Min: 0.74  Med: 2.51 Max: 6.45
Current: 2.79
0.74
6.45
Shiller P/E 17.93
HCA's Shiller P/E is ranked higher than
67% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. HCA: 17.93 )
Ranked among companies with meaningful Shiller P/E only.
HCA' s Shiller P/E Range Over the Past 10 Years
Min: 6.14  Med: 12.32 Max: 23.14
Current: 17.93
6.14
23.14
Current Ratio 1.70
HCA's Current Ratio is ranked higher than
65% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. HCA: 1.70 )
Ranked among companies with meaningful Current Ratio only.
HCA' s Current Ratio Range Over the Past 10 Years
Min: 0.81  Med: 1.51 Max: 1.9
Current: 1.7
0.81
1.9
Quick Ratio 1.44
HCA's Quick Ratio is ranked higher than
59% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 1.23 vs. HCA: 1.44 )
Ranked among companies with meaningful Quick Ratio only.
HCA' s Quick Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.33 Max: 1.68
Current: 1.44
0.71
1.68
Days Inventory 74.67
HCA's Days Inventory is ranked lower than
88% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 18.01 vs. HCA: 74.67 )
Ranked among companies with meaningful Days Inventory only.
HCA' s Days Inventory Range Over the Past 10 Years
Min: 54.26  Med: 65.41 Max: 74.73
Current: 74.67
54.26
74.73
Days Sales Outstanding 53.31
HCA's Days Sales Outstanding is ranked lower than
65% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 42.78 vs. HCA: 53.31 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.84  Med: 52.29 Max: 56.3
Current: 53.31
44.84
56.3
Days Payable 105.68
HCA's Days Payable is ranked higher than
74% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. HCA: 105.68 )
Ranked among companies with meaningful Days Payable only.
HCA' s Days Payable Range Over the Past 10 Years
Min: 108.24  Med: 112.98 Max: 119.5
Current: 105.68
108.24
119.5

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.80
HCA's Price/Projected FCF is ranked lower than
55% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 1.51 vs. HCA: 1.80 )
Ranked among companies with meaningful Price/Projected FCF only.
HCA' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.82  Med: 3.92 Max: 17.85
Current: 1.8
1.82
17.85
Price/DCF (Earnings Based) 1.36
HCA's Price/DCF (Earnings Based) is ranked higher than
69% of the 29 Companies
in the Global Medical Care industry.

( Industry Median: 1.64 vs. HCA: 1.36 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.28
HCA's Price/Median PS Value is ranked lower than
71% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. HCA: 1.28 )
Ranked among companies with meaningful Price/Median PS Value only.
HCA' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.57  Med: 0.93 Max: 1.65
Current: 1.28
0.57
1.65
Price/Peter Lynch Fair Value 2.20
HCA's Price/Peter Lynch Fair Value is ranked higher than
54% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 2.78 vs. HCA: 2.20 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HCA' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.79  Med: 2.23 Max: 3.67
Current: 2.2
0.79
3.67
Earnings Yield (Greenblatt) (%) 9.24
HCA's Earnings Yield (Greenblatt) (%) is ranked higher than
88% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. HCA: 9.24 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HCA' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 8  Med: 9.30 Max: 16
Current: 9.24
8
16
Forward Rate of Return (Yacktman) (%) 13.01
HCA's Forward Rate of Return (Yacktman) (%) is ranked higher than
62% of the 104 Companies
in the Global Medical Care industry.

( Industry Median: 10.08 vs. HCA: 13.01 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HCA' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9  Med: 13.00 Max: 17.6
Current: 13.01
9
17.6

More Statistics

Revenue (TTM) (Mil) $40,262
EPS (TTM) $ 5.31
Beta0.35
Short Percentage of Float3.43%
52-Week Range $43.91 - 95.49
Shares Outstanding (Mil)391.05

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 43,101 45,241 51,922
EPS ($) 6.37 6.99 7.73
EPS w/o NRI ($) 6.37 6.99 7.73
EPS Growth Rate
(3Y to 5Y Estimate)
12.02%
» More Articles for HCA

Headlines

Articles On GuruFocus.com
Richard Perry Trims Time Warner, AIG Jun 20 2016 
All-In-One Screener Finds Week's Largest Insider Trades May 13 2016 
Samuel Isaly's Eaton Vance Worldwide Health Sciences Fund Q1 Investment Report May 13 2016 
Value Stocks? Really? Apr 06 2016 
Richard Perry Invests in 3 Energy Stocks in 4th Quarter Feb 26 2016 
An Overview of Appaloosa Management's Top 3 Holdings Dec 24 2015 
Steve Mandel Closes Position in Lowe's Dec 10 2015 
Tepper Boosts Stake in TerraForm Power, Increases Pressure on Board Dec 08 2015 
Vanguard Raises Stakes in Biogen, Mylan, Merck Nov 15 2015 
Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer Nov 02 2015 

More From Other Websites
Entrepreneur Center strengthens ties with HCA Jun 27 2016
HCA Holdings, Inc. breached its 50 day moving average in a Bearish Manner : HCA-US : June 27, 2016 Jun 27 2016
Top of the List: Employers Jun 27 2016
Quest Diagnostics Poised on Strategic Tie-Ups, New Launches Jun 27 2016
What does the Brexit mean for HCA and Acadia? Jun 24 2016
Coverage initiated on HCA by Bernstein Jun 16 2016
Hedge Funds’ Favorite Medical Care Stocks Jun 13 2016
First board of trustees chosen for Oviedo Medical Center Jun 10 2016
HCA Holdings, Inc. – Value Analysis (NYSE:HCA) : June 9, 2016 Jun 09 2016
HCA Holdings, Inc. breached its 50 day moving average in a Bullish Manner : HCA-US : June 8, 2016 Jun 08 2016
Nashville’s Fortune 500 companies reeled in more than $100B in revenue last year Jun 06 2016
HCA to Present at June Healthcare Conference Jun 03 2016
HCA to Present at June Healthcare Conference Jun 03 2016
Where The Big Short Is Finding Value Jun 01 2016
Wide Ranging Interview With Larry Robbins On The Future Of Hedge funds And More May 31 2016
Quest Diagnostics and HCA's HealthONE System Partner to Deliver High-Value and Innovative Laboratory... May 31 2016
Quest Diagnostics and HCA's HealthONE System Partner to Deliver High-Value and Innovative Laboratory... May 31 2016
An Income Strategy That Doesn't Require Dividends May 25 2016
Billionaire Larry Robbins’ Top Healthcare Picks for Q2 May 20 2016
13F Summary For Q1 May 17 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)